ロード中...

Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways

BACKGROUND: Metformin is a commonly used drug for the treatment of diabetes. Accumulating evidence suggests that it exerts anti-tumor effects in many cancers, including multiple myeloma (MM); however, the underlying molecular mechanisms have not been clearly elucidated. METHODS: The anti-myeloma eff...

詳細記述

保存先:
書誌詳細
出版年:J Exp Clin Cancer Res
主要な著者: Wang, Yan, Xu, Wenbin, Yan, Zixun, Zhao, Weili, Mi, Jianqing, Li, Junmin, Yan, Hua
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859411/
https://ncbi.nlm.nih.gov/pubmed/29554968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0731-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!